Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Fauci becomes consultant of Biotecnopolo hub in Siena

Fauci becomes consultant of Biotecnopolo hub in Siena

Nobel winner Parisi satisfied, sees hub for pandemic prevention

ROME, 29 March 2023, 18:09

Redazione ANSA

ANSACheck

© ANSA/EPA

© ANSA/EPA
© ANSA/EPA

American immunologist Anthony Fauci has agreed to act in an informal capacity as a strategic advisor to Rino Rappuoli, scientific director of the Biotecnopolo biotech hub in Siena, an institution founded by the Ministries of the University, Health, Economy and Industry with the aim of focusing on applied research in biotechnologies and life sciences, the Fondazione Biotecnopolo announced this week.
    The availability of the 82-year-old Fauci, one of the leading global experts in the field of infectious diseases and medical advisor to seven presidents of the United States, was welcomed by Nobel Prize winner Giorgio Parisi, a member of the foundation's board.
    "Fauci's willingness to act as an informal advisor," Parisi said, "is a fundamental step towards making the Biotecnopolo the Italian hub for the research, study and prevention of pandemics".
    The Biotecnopolo, he observed, is in fact a concrete product of the document 'Preparation for pandemics and the role of science', issued by the Accademia Nazionale dei Lincei and endorsed by the Academies of the G20 in 2021. "Fauci has decades-long relations with Italian scientists." These ties, underscored Parisi, "show how highly the value and rigour of Italian sciences are recognised: they are the most concrete stimulus to beginning, as soon as possible, the activity of a Centre that can represent global recognition of the excellence of Italian science".
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.